<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39339937</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Seropositivity in Nursing Home Staff and Residents during the First SARS-CoV-2 Wave in Flanders, Belgium.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1461</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16091461</ELocationID><Abstract><AbstractText>(1) Background: early in the COVID-19 pandemic, reverse transcription polymerase chain reaction (RT-PCR) testing was limited. Assessing seroprevalence helps understand prevalence and reinfection risk. However, such data are lacking for the first epidemic wave in Belgian nursing homes. Therefore, we assessed SARS-CoV-2 seroprevalence and cumulative RT-PCR positivity in Belgian nursing homes and evaluated reinfection risk. (2) Methods: we performed a cross-sectional study in nine nursing homes in April and May 2020. Odds ratios (ORs) were calculated to compare the odds of (re)infection between seropositive and seronegative participants. (3) Results: seroprevalence was 21% (95% CI: 18-23): 22% (95% CI: 18-25) in residents and 20% (95% CI: 17-24) in staff. By 20 May 2020, cumulative RT-PCR positivity was 16% (95% CI: 13-21) in residents and 8% (95% CI: 6-12) in staff. ORs for (re)infection in seropositive (compared to seronegative) residents and staff were 0.22 (95% CI: 0.06-0.72) and 3.15 (95% CI: 1.56-6.63), respectively. (4) Conclusion: during the first wave, RT-PCR test programmes underestimated the number of COVID-19 cases. The reinfection rate in residents was 3%, indicating protection, while it was 21% in staff, potentially due to less cautious health behaviour. Future outbreaks should use both RT-PCR and serological testing for complementary insights into transmission dynamics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Rop</LastName><ForeName>Liselore</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0111-9508</Identifier><AffiliationInfo><Affiliation>LUHTAR, Department of Public Health and Primary Care, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vercruysse</LastName><ForeName>Hanne</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Research and Analytics, Liantis Occupational Health Services, 8000 Bruges, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alenus</LastName><ForeName>Ulysse</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brusselmans</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callens</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine &amp; Infectious Diseases, Ghent University Hospital, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claeys</LastName><ForeName>Maud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Coene</LastName><ForeName>Nimphe</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Persyn</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Department, Korian Belgium NH, 2550 Kontich, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padalko</LastName><ForeName>Elizaveta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Biology, University Hospital Ghent, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heytens</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1097-4987</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verbakel</LastName><ForeName>Jan Y</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0002-7166-7211</Identifier><AffiliationInfo><Affiliation>LUHTAR, Department of Public Health and Primary Care, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cools</LastName><ForeName>Piet</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2980-5307</Identifier><AffiliationInfo><Affiliation>Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BOF.COV.2020.0010.01</GrantID><Agency>Special Research Fund of Ghent University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001530" MajorTopicYN="N" Type="Geographic">Belgium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009735" MajorTopicYN="Y">Nursing Homes</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000084063" MajorTopicYN="N">Reinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087124" MajorTopicYN="N">COVID-19 Serological Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">RT-PCR testing</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">nursing homes</Keyword><Keyword MajorTopicYN="N">reinfection</Keyword><Keyword MajorTopicYN="N">seroprevalence</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39339937</ArticleId><ArticleId IdType="pmc">PMC11437469</ArticleId><ArticleId IdType="doi">10.3390/v16091461</ArticleId><ArticleId IdType="pii">v16091461</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Peeters I., Vermeulen M., Bustos Sierra N., Renard F., Van der Heyden J., Scohy A., Braeye T., Bossuyt N., Haarhuis F., Proesmans K., et al.  Surveillance of COVID-19 Mortality in Belgium, Epidemiology and Methodology during 1st and 2nd Wave (March 2020–14 February 2021). 2021. Report No.: D/2021/14.440/57. .  [(accessed on 6 July 2022)].  Available online:  https://covid-19.sciensano.be/fr/covid-19-situation-epidemiologique.</Citation></Reference><Reference><Citation>McMichael T.M., Currie D.W., Clark S., Pogosjans S., Kay M., Schwartz N.G., Lewis J., Baer A., Kawakami V., Lukoff M.D., et al. Epidemiology of COVID-19 in a Long-Term Care Facility in King County, Washington. N. Engl. J. Med. 2020;382:2005–2011. doi: 10.1056/NEJMoa2005412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2005412</ArticleId><ArticleId IdType="pmc">PMC7121761</ArticleId><ArticleId IdType="pubmed">32220208</ArticleId></ArticleIdList></Reference><Reference><Citation>Arons M.M., Hatfield K.M., Reddy S.C., Kimball A., James A., Jacobs J.R., Taylor J., Spicer K., Bardossy A.C., Oakley L.P., et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N. Engl. J. Med. 2020;382:2081–2090. doi: 10.1056/NEJMoa2008457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2008457</ArticleId><ArticleId IdType="pmc">PMC7200056</ArticleId><ArticleId IdType="pubmed">32329971</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham N.S.N., Junghans C., McLaren R., Randell P., Lang N., Ladhani S.N., Sharp D.J., Sanderson F. High rates of SARS-CoV-2 seropositivity in nursing home residents. J. Infect. 2021;82:282–327. doi: 10.1016/j.jinf.2020.08.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.040</ArticleId><ArticleId IdType="pmc">PMC7449890</ArticleId><ArticleId IdType="pubmed">32860817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladhani S.N., Jeffery-Smith A., Patel M., Janarthanan R., Fok J., Crawley-Boevey E., Vusirikala A., Fernandez Ruiz De Olano E., Perez M.S., Tang S., et al. High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England. EClinicalMedicine. 2020;28:100597. doi: 10.1016/j.eclinm.2020.100597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100597</ArticleId><ArticleId IdType="pmc">PMC7644437</ArticleId><ArticleId IdType="pubmed">33173854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallett S., Allen A.J., Graziadio S., Taylor S.A., Sakai N.S., Green K., Suklan J., Hyde C., Shinkins B., Zhelev Z., et al. At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data. BMC Med. 2020;18:346. doi: 10.1186/s12916-020-01810-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01810-8</ArticleId><ArticleId IdType="pmc">PMC7609379</ArticleId><ArticleId IdType="pubmed">33143712</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC Public Health Emergency Team. Danis K., Fonteneau L., Georges S., Daniau C., Bernard-Stoecklin S., Domegan L., O’Donnell J., Hauge S.H., Dequeker S., et al. High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020. Euro Surveill. 2020;25:2000956. doi: 10.2807/1560-7917.ES.2020.25.22.2000956.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.22.2000956</ArticleId><ArticleId IdType="pmc">PMC7336111</ArticleId><ArticleId IdType="pubmed">32524949</ArticleId></ArticleIdList></Reference><Reference><Citation>Berselli N., Filippini T., Paduano S., Malavolti M., Modenese A., Gobba F., Borella P., Marchesi I., Vivoli R., Perlini P., et al. Seroprevalence of anti-SARS-CoV-2 antibodies in the Northern Italy population before the COVID-19 second wave. Int. J. Occup. Med. Environ. Health. 2022;35:63–74. doi: 10.13075/ijomeh.1896.01826.</Citation><ArticleIdList><ArticleId IdType="doi">10.13075/ijomeh.1896.01826</ArticleId><ArticleId IdType="pmc">PMC10464740</ArticleId><ArticleId IdType="pubmed">34524275</ArticleId></ArticleIdList></Reference><Reference><Citation>Paduano S., Galante P., Berselli N., Ugolotti L., Modenese A., Poggi A., Malavolti M., Turchi S., Marchesi I., Vivoli R., et al. Seroprevalence Survey of Anti-SARS-CoV-2 Antibodies in a Population of Emilia-Romagna Region, Northern Italy. Int. J. Environ. Res. Public Health. 2022;19:7882. doi: 10.3390/ijerph19137882.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19137882</ArticleId><ArticleId IdType="pmc">PMC9266015</ArticleId><ArticleId IdType="pubmed">35805539</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahav D., Yelin D., Eckerle I., Eberhardt C.S., Wang J., Cao B., Kaiser L. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin. Microbiol. Infect. 2021;27:315–318. doi: 10.1016/j.cmi.2020.11.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.11.028</ArticleId><ArticleId IdType="pmc">PMC7718119</ArticleId><ArticleId IdType="pubmed">33285276</ArticleId></ArticleIdList></Reference><Reference><Citation>Krutikov M., Palmer T., Tut G., Fuller C., Shrotri M., Williams H., Davies D., Irwin-Singer A., Robson J., Hayward A., et al. Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): A prospective cohort study. Lancet Healthy Longev. 2021;2:e362–e370. doi: 10.1016/S2666-7568(21)00093-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(21)00093-3</ArticleId><ArticleId IdType="pmc">PMC8175048</ArticleId><ArticleId IdType="pubmed">34104901</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey R.A., Rassen J.A., Kabelac C.A., Turenne W., Leonard S., Klesh R., Meyer W.A., 3rd, Kaufman H.W., Anderson S., Cohen O., et al. Association of SARS-CoV-2 Seropositive Antibody Test with Risk of Future Infection. JAMA Intern. Med. 2021;181:672–679. doi: 10.1001/jamainternmed.2021.0366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.0366</ArticleId><ArticleId IdType="pmc">PMC7905701</ArticleId><ArticleId IdType="pubmed">33625463</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Coronavirus Disease (COVID-19) Pandemic [Internet]  [(accessed on 21 November 2023)].  Available online:  https://www.who.int/europe/emergencies/situations/covid-19.</Citation></Reference><Reference><Citation>Catteau L., Haarhuis F., Dequeker S., Vandael E., Stouten V., Litzroth A., Wyndham Thomas C. Surveillance Van de COVID-19 Vaccinatie in Belgische Woonzorgcentra. Resultaten tot 24.maart 2021. 2021. Report No.: D/2021/14.440/32.  [(accessed on 25 August 2024)].  Available online:  https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_THEMATIC%20REPORT_SURVEILLANCE%20VAN%20DE%20VACCINATIE%20IN%20BELGISCHE%20WOONZORGCENTRA.pdf.</Citation></Reference><Reference><Citation>Cools P., Callens S., Devleesschauwer B., Levecke B., Padalko E. De Performantie Van Speekselstalen Voor de Moleculaire Detectie van SARS-CoV-2 en Een Speeksel Pooling Strategie als Diagnostische Tool Voor Epidemiologische Studies in de Huidige SARS-CoV-2 Pandemie.  [(accessed on 12 February 2024)].  Available online:  https://researchportal.be/nl/project/de-performantie-van-speekselstalen-voor-de-moleculaire-detectie-van-sars-cov-2-en-een.</Citation></Reference><Reference><Citation>Hoxha A., Wyndham-Thomas C., Klamer S., Dubourg D., Vermeulen M., Hammami N., Cornelissen L. Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities. Lancet Infect. Dis. 2021;21:e67. doi: 10.1016/S1473-3099(20)30560-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30560-0</ArticleId><ArticleId IdType="pmc">PMC7333983</ArticleId><ArticleId IdType="pubmed">32628906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciensano  Belgium COVID-19 Epidemiological Situation [Internet]  [(accessed on 20 February 2024)].  Available online:  https://datastudio.google.com/embed/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB.</Citation></Reference><Reference><Citation>Sciensano  Aantal Bloeddonoren en Gezondheidswerkers met Antistoffen Tegen Coronavirus Blijft Stabiel [Internet]  [(accessed on 20 February 2024)].  Available online:  https://www.sciensano.be/nl/pershoek/aantal-bloeddonoren-en-gezondheidswerkers-met-antistoffen-tegen-coronavirus-blijft-stabiel.</Citation></Reference><Reference><Citation>Steensels D., Oris E., Coninx L., Nuyens D., Delforge M.L., Vermeersch P., Heylen L. Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium. JAMA. 2020;324:195–197. doi: 10.1001/jama.2020.11160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.11160</ArticleId><ArticleId IdType="pmc">PMC7296458</ArticleId><ArticleId IdType="pubmed">32539107</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustos Sierra N., Bossuyt N., Braeye T., Leroy M., Moyersoen I., Peeters I., Scohy A., Van der Heyden J., Van Oyen H., Renard F. All-cause mortality supports the COVID-19 mortality in Belgium and comparison with major fatal events of the last century. Arch. Public Health. 2020;78:117. doi: 10.1186/s13690-020-00496-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13690-020-00496-x</ArticleId><ArticleId IdType="pmc">PMC7662738</ArticleId><ArticleId IdType="pubmed">33292536</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelisssen L., De Muylder G., Lafort Y., Laisnez V., Litzroth A., Stefani G., Stouten V., Van Valkenborgh E., Wyndham Thomas C. FACT SHEET: COVID-19 Disease (SARS-CoV-2 Virus)  [(accessed on 15 March 2024)].  Available online:  https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_fact_sheet_ENG.pdf.</Citation></Reference><Reference><Citation>Janssens H., Heytens S., Meyers E., De Schepper E., De Sutter A., Devleesschauwer B., Formukong A., Keirse S., Padalko E., Geens T., et al. Pre-vaccination SARS-CoV-2 seroprevalence among staff and residents of nursing homes in Flanders (Belgium) in fall 2020. Epidemiol. Infect. 2022;150:e65. doi: 10.1017/S095026882200036X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S095026882200036X</ArticleId><ArticleId IdType="pmc">PMC8943225</ArticleId><ArticleId IdType="pubmed">35234113</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortgat L., Verdonck K., Hutse V., Thomas I., Barbezange C., Heyndrickx L., Fischer N., Vuylsteke B., Kabouche I., Ariën K.K., et al. Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: A prospective cohort study. BMJ Open. 2021;11:50824. doi: 10.1136/bmjopen-2021-050824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-050824</ArticleId><ArticleId IdType="pmc">PMC8245288</ArticleId><ArticleId IdType="pubmed">34187832</ArticleId></ArticleIdList></Reference><Reference><Citation>Roda W.C., Varughese M.B., Han D., Li M.Y. Why is it difficult to accurately predict the COVID-19 epidemic? Infect. Dis. Model. 2020;5:271–281. doi: 10.1016/j.idm.2020.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7104073</ArticleId><ArticleId IdType="pubmed">32289100</ArticleId></ArticleIdList></Reference><Reference><Citation>White E.M., Saade E.A., Yang X., Canaday D.H., Blackman C., Santostefano C.M., Nanda A., Feifer R.A., Mor V., Rudolph J.L., et al. SARS-CoV-2 antibody detection in skilled nursing facility residents. J. Am. Geriatr. Soc. 2021;69:1722–1728. doi: 10.1111/jgs.17061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17061</ArticleId><ArticleId IdType="pmc">PMC8013911</ArticleId><ArticleId IdType="pubmed">33544876</ArticleId></ArticleIdList></Reference><Reference><Citation>Krajewski R., Gołębiowska J., Makuch S., Mazur G., Agrawal S. Update on serologic testing in COVID-19. Clin. Chim. Acta. 2020;510:746–750. doi: 10.1016/j.cca.2020.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.09.015</ArticleId><ArticleId IdType="pmc">PMC7491380</ArticleId><ArticleId IdType="pubmed">32946795</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffery-Smith A., Iyanger N., Williams S.V., Chow J.Y., Aiano F., Hoschler K., Lackenby A., Ellis J., Platt S., Miah S., et al. Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill. 2021;26:2100092. doi: 10.2807/1560-7917.ES.2021.26.5.2100092.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.5.2100092</ArticleId><ArticleId IdType="pmc">PMC7863231</ArticleId><ArticleId IdType="pubmed">33541486</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumley S.F., O’Donnell D., Stoesser N.E., Matthews P.C., Howarth A., Hatch S.B., Marsden B.D., Cox S., James T., Warren F., et al. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. N. Engl. J. Med. 2021;384:533–540. doi: 10.1056/NEJMoa2034545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034545</ArticleId><ArticleId IdType="pmc">PMC7781098</ArticleId><ArticleId IdType="pubmed">33369366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins J.T., Hirschhorn L.R., Gray E.L., Wallia A., Carnethon M., Zembower T.R., Ho J., DeYoung B.J., Zhu A., Rasmussen-Torvik L.J., et al. Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort Study. Infect. Control Hosp. Epidemiol. 2022;43:1207–1215. doi: 10.1017/ice.2021.367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2021.367</ArticleId><ArticleId IdType="pmc">PMC8438416</ArticleId><ArticleId IdType="pubmed">34369331</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall V.J., Foulkes S., Charlett A., Atti A., Monk E.J.M., Simmons R., Wellington E., Cole M.J., Saei A., Oguti B., et al. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: A large, multicentre, prospective cohort study (SIREN) Lancet. 2021;397:1459–1469. doi: 10.1016/S0140-6736(21)00675-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00675-9</ArticleId><ArticleId IdType="pmc">PMC8040523</ArticleId><ArticleId IdType="pubmed">33844963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen C.H., Michlmayr D., Gubbels S.M., Molbak K., Ethelberg S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: A population-level observational study. Lancet. 2021;397:1204–1212. doi: 10.1016/S0140-6736(21)00575-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00575-4</ArticleId><ArticleId IdType="pmc">PMC7969130</ArticleId><ArticleId IdType="pubmed">33743221</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinbami L.J., Biggerstaff B.J., Chan P.A., McGibbon E., Pathela P., Petersen L.R. Reinfection with Severe Acute Respiratory Syndrome Coronavirus 2 Among Previously Infected Healthcare Personnel and First Responders. Clin. Infect. Dis. 2022;75:e201–e207. doi: 10.1093/cid/ciab952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab952</ArticleId><ArticleId IdType="pmc">PMC8767877</ArticleId><ArticleId IdType="pubmed">34791108</ArticleId></ArticleIdList></Reference><Reference><Citation>Spicer K.B., Glick C., Cavanaugh A.M., Thoroughman D. Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)—Kentucky, USA, 2020. Int. J. Infect. Dis. 2022;114:21–28. doi: 10.1016/j.ijid.2021.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.10.010</ArticleId><ArticleId IdType="pmc">PMC8506664</ArticleId><ArticleId IdType="pubmed">34649001</ArticleId></ArticleIdList></Reference><Reference><Citation>Adlhoch C., Carvalho C., Lamb F., Leitmeyer K., Omokanye A., Pharris A., Plachouras D., Spiteri G. Reinfection with SARS-CoV-2: Implementation of a Surveillance Case Definition within the EU/EEA.  [(accessed on 20 February 2024)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/reinfection-sars-cov-2-implementation-surveillance-case-definition-within-eueea.</Citation></Reference><Reference><Citation>Cento V., Colagrossi L., Nava A., Lamberti A., Senatore S., Travi G., Rossotti R., Vecchi M., Casati O., Matarazzo E., et al. Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients. J. Infect. 2020;81:e90–e92. doi: 10.1016/j.jinf.2020.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.024</ArticleId><ArticleId IdType="pmc">PMC7836522</ArticleId><ArticleId IdType="pubmed">32574567</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Infection Prevention and Control Guidance for Long-Term Care Facilities in the Context of COVID-19: Interim Guidance, 8 January 2021. 2021.  [(accessed on 18 March 2024)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC_long_term_care-2021.1.</Citation></Reference><Reference><Citation>White E.M., Kosar C.M., Feifer R.A., Blackman C., Gravenstein S., Ouslander J., Mor V. Variation in SARS-CoV-2 Prevalence in U.S. Skilled Nursing Facilities. J. Am. Geriatr. Soc. 2020;68:2167–2173. doi: 10.1111/jgs.16752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16752</ArticleId><ArticleId IdType="pmc">PMC7404330</ArticleId><ArticleId IdType="pubmed">32674223</ArticleId></ArticleIdList></Reference><Reference><Citation>Malikov K., Huang Q., Shi S., Stall N.M., Tuite A.R., Hillmer M.P. Temporal Associations between Community Incidence of COVID-19 and Nursing Home Outbreaks in Ontario, Canada. J. Am. Med. Dir. Assoc. 2021;22:260–262. doi: 10.1016/j.jamda.2020.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2020.12.011</ArticleId><ArticleId IdType="pmc">PMC7749642</ArticleId><ArticleId IdType="pubmed">33476568</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges R.J., Konetzka R.T. Staffing Levels and COVID-19 Cases and Outbreaks in U.S. Nursing Homes. J. Am. Geriatr. Soc. 2020;68:2462–2466. doi: 10.1111/jgs.16787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16787</ArticleId><ArticleId IdType="pmc">PMC7436613</ArticleId><ArticleId IdType="pubmed">32770832</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>